Primary mitochondrial disorders and mimics: Insights from a large French cohort

• Published in: Annals of clinical and translational neurology Vol. 11; no. 6; pp. 1478 - 1491
• Main Authors: Rouzier, Cécile, Pion, Emmanuelle, Chaussenot, Annabelle, Bris, Céline, Ait‐El‐Mkadem Saadi, Samira, Desquiret‐Dumas, Valérie, Gueguen, Naïg, Fragaki, Konstantina, Amati‐Bonneau, Patrizia, Barcia, Giulia, Gaignard, Pauline, Steffann, Julie, Pennisi, Alessandra, Bonnefont, Jean‐Paul, Lebigot, Elise, Bannwarth, Sylvie, Francou, Bruno, Rucheton, Benoit, Sternberg, Damien, Martin‐Negrier, Marie‐Laure, Trimouille, Aurélien, Hardy, Gaëlle, Allouche, Stéphane, Acquaviva‐Bourdain, Cécile, Pagan, Cécile, Lebre, Anne‐Sophie, Reynier, Pascal, Cossee, Mireille, Attarian, Shahram, Paquis‐Flucklinger, Véronique, Procaccio, Vincent
• Format: Journal Article
• Language: English
• Published: United States John Wiley & Sons, Inc 01.06.2024; Wiley; John Wiley and Sons Inc
• Subjects: Adults; Age; Disease; Endocrinology and metabolism; Genes; Genetic testing; Genetics; Genomics; Genotype & phenotype; Histology; Human genetics; Human health and pathology; Laboratories; Life Sciences; Mitochondrial DNA; Patients; Populations and Evolution
• ISSN: 2328-9503; 2328-9503
• DOI: 10.1002/acn3.52062

Objective The objective of this study was to evaluate the implementation of NGS within the French mitochondrial network, MitoDiag, from targeted gene panels to whole exome sequencing (WES) or whole genome sequencing (WGS) focusing on mitochondrial nuclear‐encoded genes. Methods Over 2000 patients suspected of Primary Mitochondrial Diseases (PMD) were sequenced by either targeted gene panels, WES or WGS within MitoDiag. We described the clinical, biochemical, and molecular data of 397 genetically confirmed patients, comprising 294 children and 103 adults, carrying pathogenic or likely pathogenic variants in nuclear‐encoded genes. Results The cohort exhibited a large genetic heterogeneity, with the identification of 172 distinct genes and 253 novel variants. Among children, a notable prevalence of pathogenic variants in genes associated with oxidative phosphorylation (OXPHOS) functions and mitochondrial translation was observed. In adults, pathogenic variants were primarily identified in genes linked to mtDNA maintenance. Additionally, a substantial proportion of patients (54% (42/78) and 48% (13/27) in children and adults, respectively), undergoing WES or WGS testing displayed PMD mimics, representing pathologies that clinically resemble mitochondrial diseases. Interpretation We reported the largest French cohort of patients suspected of PMD with pathogenic variants in nuclear genes. We have emphasized the clinical complexity of PMD and the challenges associated with recognizing and distinguishing them from other pathologies, particularly neuromuscular disorders. We confirmed that WES/WGS, instead of panel approach, was more valuable to identify the genetic basis in patients with “possible” PMD and we provided a genetic testing flowchart to guide physicians in their diagnostic strategy.